HUMA
Humacyte, Inc.Company with tickers: HUMA, HUMAW
CIK
1818382
CUSIP
44486Q103
Shares Outstanding
222,019,108
13F Activity (30d)
134 filings
131 filers
Price
$1.09
Market Cap
$246.44M
P/E Ratio
-4.17
EPS (Diluted)
$-0.26
52W High
$2.93
52W Low
$0.55
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $495,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $19,462,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Operating Income | $-28,935,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| Net Income | $-17,619,000 | USD | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Basic) | $-0.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |
| EPS (Diluted) | $-0.09 | USD/shares | 2026-03-31 | 10-Q | 2026-05-13 |